An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) Agent
Clinical trial NCT01641952 · COMPLETED
Trial details
- NCT number
- NCT01641952
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-10-01
- Primary completion
- 2015-01-01
- Enrollment
- 505
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.